Power Law company profile

Mirum Pharmaceuticals

Biotech & Life Sciences · Foster City, United States · Founded 2018 · IPO 2019 Thoroughbred

Mirum Pharmaceuticals is a clinical-stage therapeutics company

Valuation

$5.87B

Market cap · May/2026

Revenue

$520M

Latest reported FY

EBITDA

$17M

Latest reported FY

Featured in $10B+ revenueThoroughbred · Power Law outcome

Investors

7 investors on Mirum Pharmaceuticals's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 6 investors entered at this stage

Novo Holdings

RiverVest Venture Partners

Frazier Healthcare Partners

NEA

Rock Springs Capital

Deerfield

Series B+ 1 investor entered at this stage

TCGX

Global footprint

Where Mirum Pharmaceuticals has talent and traffic

Workforce by country

10 countries with
team presence

🇺🇸 United States76.9%

🇨🇭 Switzerland14.2%

🇮🇹 Italy2.5%

🇫🇷 France1.4%

🇪🇸 Spain1.1%

Top 5 of 10 shown

Web traffic by country

22K monthly visits
across markets

🇺🇸 United States56.4%

🇮🇳 India10%

🇨🇭 Switzerland9.1%

🇬🇧 United Kingdom8.2%

🇨🇦 Canada7.7%

Top 5 markets shown

Market sentiment

What the market is saying about Mirum Pharmaceuticals

An AI-synthesized read of the highest-engagement posts about Mirum Pharmaceuticals on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Mirum Pharmaceuticals on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles